Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Multiple Myeloma and Myelodysplastic Syndromes.
Multiple Myeloma and Myelodysplastic Syndromes.
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Relapsed or refractory B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma, Mantle Cell Lymphoma, or Multiple Myeloma.
Melanoma, Non-Small Cell Lung Cancer, Renal Cell Carcinoma, Urothelial Cancer, Head and Neck Cancer, MSI-H/dMMR solid tumors, and Cervical Cancer.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Hodgkin Lymphoma, CD30-expressing T-cell lymphomas, Urothelial Carcinoma, Cervical Cancer, or Diffuse Large B-cell Lymphoma.
Approved for use in oncology care according to FDA-approved indications.
Targeted treatment of solid tumors and hematologic malignancies.